16 employees
Reprieve Cardiovascular is focused on improving outcomes for patients suffering from acute decompensated heart failure.
2018
$7M
from 1 investors over 1 rounds
Reprieve Cardiovascular raised $7M on September 12, 2018
Investors: Abiomed